Apart from TGF-β1, pancreatic cancer-derived EVs also contained multiple other immune regulatory factors, such as PVR and nectin-2, which could be delivered as inhibitory signals to NK cells. The gene discussed is NECTIN2; the disease is pancreatic neoplasm.